As a clinically relevant biological marker, CD36 is associated with cardiovascular biology (e.g., atherosclerosis, angiogenesis, and ischemia-reperfusion injury), cardiac metabolism in the uptake of free fatty acids, and inflammatory related pathologies. This evidence concerns the gene CD36 and atherosclerosis.